A case of nivolumab-induced cervical lymphadenopathy in a patient with gastric cancer

Nivolumab is a monoclonal antibody targeting programmed cell death-1 (PD-1) that has been recently shown to exhibit clinical efficacy in patients with gastric cancer. However, various degrees of immune-related adverse events (irAEs) have been reported. We report the case of a 71-year-old male patien...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :J Gastrointest Oncol
Главные авторы: Taira, Koichi, Kimura, Akie, Nakata, Akinobu, Nadatani, Yuji, Fukunaga, Shusei, Otani, Koji, Hosomi, Shuhei, Tanaka, Fumio, Kamata, Noriko, Nagami, Yasuaki, Watanabe, Toshio, Fujiwara, Yasuhiro
Формат: Artigo
Язык:Inglês
Опубликовано: AME Publishing Company 2021
Предметы:
Case Report
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC8107580/
https://ncbi.nlm.nih.gov/pubmed/34012675
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jgo-20-315
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы